Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Receivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

AC Immune (ACIU) Total Non-Current Liabilities: 2015-2025

Historic Total Non-Current Liabilities for AC Immune (ACIU) over the last 11 years, with Sep 2025 value amounting to $13.6 million.

  • AC Immune's Total Non-Current Liabilities fell 10.05% to $13.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $13.6 million, marking a year-over-year decrease of 10.05%. This contributed to the annual value of $13.6 million for FY2025, which is N/A change from last year.
  • Per AC Immune's latest filing, its Total Non-Current Liabilities stood at $13.6 million for FY2025, which was up 66,798.87% from $20,325 recorded in FY2024.
  • Over the past 5 years, AC Immune's Total Non-Current Liabilities peaked at $13.6 million during FY2025, and registered a low of $9,690 during FY2023.
  • For the 3-year period, AC Immune's Total Non-Current Liabilities averaged around $4.5 million, with its median value being $20,325 (2024).
  • Its Total Non-Current Liabilities has fluctuated over the past 5 years, first slumped by 99.83% in 2023, then skyrocketed by 109.76% in 2024.
  • Yearly analysis of 5 years shows AC Immune's Total Non-Current Liabilities stood at $10.3 million in 2021, then slumped by 45.07% to $5.7 million in 2022, then crashed by 99.83% to $9,690 in 2023, then skyrocketed by 109.76% to $20,325 in 2024, then reached $13.6 million in 2025.